Business

Defence Therapeutics Announces AGM Results and Provides Corporate Updates

Montreal, Quebec--(Newsfile Corp. - December 10, 2025) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a biotechnology company advancing a proprietary intracellular delivery platform that enables more potent, safer, and more effective antibody-based and radiotherapeutic treatments, is pleased to announce that the Shareholders approved all matters presented at the Company's annual general meeting of the shareholders held today, as follows:Setting the

articleDefence Therapeutics Inc Class ADecember 10, 20254/company/defence-therapeutics-inc/news/defence-therapeutics-announces-agm-results-213000722
Defence Therapeutics Announces AGM Results and Provides Corporate Updates

About this update from Defence Therapeutics Inc Class A

[{"type":"text","content":"Montreal, Quebec--(Newsfile Corp. - December 10, 2025) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a biotechnology company advancing a proprietary intracellular delivery platform that enables more potent, safer, and more effective antibody-based and radiotherapeutic treatments, is pleased to announce that the Shareholders approved all matters presented at the Company's annual general meeting of the shareholders held today, as follows:","length":513,"tagName":"p"},{"type":"table","headerItems":[],"items":[{"val":[{"style":"width:50%;","val":[{"type":"list","items":[{"val":[{"type":"text","content":"Setting the number of directors at five","length":39,"tagName":"p"}]},{"val":[{"type":"text","content":"Election of directors:Sebastien Plouffe                                                            Dr. Philippe Lefrançois                                                   Dr. Sarkis Meterissian                                                    Dr. Svetlana Selivanova                                                 Dr. Amie Phinney  ","length":886,"tagName":"p"}]},{"val":[{"type":"text","content":"Appointment of Crowe MacKay LLP as auditors","length":43,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":968,"olType":false}]},{"style":"width:50%;vertical-align:middle;","val":[{"type":"text","content":"100%100%100%100%100%100%100%","length":35,"tagName":"p","attribs":{}}]}]}],"length":1016},{"type":"text","content":" ","length":6,"tagName":"p"},{"type":"text","content":"Grant of Options","length":16,"tagName":"p"},{"type":"text","content":"Defence has granted a total of 800,000 stock options (the "Options") to certain directors, officers and employees pursuant to the Company's Omnibus Incentive P...

More updates from Defence Therapeutics Inc Class A

DefenceThe CompanyDefence Therapeutics Inc.biotechnology companyCompanyCommon shareforward-looking statementsDefence Therapeutics